Over the last 12 months, Shoulder Innovations insiders reported no purchases and 4 sales totaling $4.2M across SEC Form 4 filings. 25% of the activity was filed under pre-arranged 10b5-1 trading plans.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 6, 2026 | Gilde Healthcare Holding B.V.10% | ▼ Sale | 9,433 | $22.63 | $213K | -0.4% | 2 tranches · indirect |
| Aug 4, 2026 | Gilde Healthcare Holding B.V.10% | ▼ Sale | 110,563 | $22.76 | $2.5M | -4.7% | 2 tranches · indirect |
| Jul 31, 2026 | Gilde Healthcare Holding B.V.10% | ▼ Sale | 48,279 | $23.1 | $1.1M | -2% | 2 tranches · indirect |
| Jun 15, 2026 | Ahearn Matthew FraserChief Operating Officer · O·D | ▼ Sale | 20,000 | $18.71 | $374K | -6.9% | plan · 3 tranches |
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $SI feed.